Autopsy report · NCT05381610

A Clinical Investigation Evaluating Peristeen® Performance

“Lack of enrollment - Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Coloplast A/S

Sponsor type

Industry

Conditions

Neurogenic Bowel

Interventions

Peristeen

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
  “Sponsor decision due to lack of enrollment.” (95% match in meaning)
• Digital Remote Home Monitoring for Heart Failure
  “Due to sponsor request for poor enrollment” (86% match in meaning)
• CorPath GRX STEMI Study
  “Low enrollment and sponsor business decision” (85% match in meaning)
• Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)
  “Lack of enrollment” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.